These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18046976)

  • 21. Angiotensin-converting enzyme inhibition as first-line treatment for hypertension.
    Thurston H
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():67-71. PubMed ID: 1395119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative efficacy of an angiotensin II antagonist compared with other antihypertensive agents. Olmesartan medoxomil versus antihypertensives.
    Ball KJ; Williams PA; Stumpe KO
    J Hypertens Suppl; 2001 Jun; 19(1):S49-56. PubMed ID: 11451215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fixed-dose combination of zofenopril plus hydrochlorothiazide vs. irbesartan plus hydrochlorothiazide in hypertensive patients with established metabolic syndrome uncontrolled by previous monotherapy. The ZAMES study (Zofenopril in Advanced MEtabolic Syndrome).
    Napoli C; Omboni S; Borghi C;
    J Hypertens; 2016 Nov; 34(11):2287-97. PubMed ID: 27653164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of captopril and atenolol in essential hypertension.
    Andrén L; Karlberg BE; Svensson A; Ohman P; Nilsson OR; Hansson L
    Acta Med Scand; 1985; 217(2):155-60. PubMed ID: 3887847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive efficacy of zofenopril plus hydrochlorothiazide fixed combination for treatment in metabolic syndrome.
    Malacco E; Omboni S
    Adv Ther; 2007; 24(5):1006-15. PubMed ID: 18029326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive efficacy and tolerability of once daily losartan potassium compared with captopril in patients with mild to moderate essential hypertension.
    Mallion JM; Bradstreet DC; Makris L; Goldberg AI; Halasz S; Sweet CS; Lim NY; Madonna O
    J Hypertens Suppl; 1995 Jul; 13(1):S35-41. PubMed ID: 18800454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data.
    Borghi C; Cicero AF
    Vasc Health Risk Manag; 2006; 2(4):341-9. PubMed ID: 17323587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing different treatment schedules of Zomen (zofenopril).
    Bălan H; Popescu E; Angelescu G
    Rom J Intern Med; 2011; 49(1):75-84. PubMed ID: 22026256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical efficacy and safety of telmisartan 80 mg once daily vs. atenolol 50 mg once daily in patients with mild-to-moderate hypertension.
    Alcocer L; Fernández-Bonetti P; Campos E; Olvera Ruiz R; Bahena J; de la Fuente JJ; Segovia-Ayala C; Dominguez-Henkel R
    Int J Clin Pract Suppl; 2004 Dec; (145):35-9. PubMed ID: 15617457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
    Ruilope LM
    Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of strict blood pressure control on proteinuria in renal patients treated with different antihypertensive drugs.
    García de Vinuesa S; Luño J; Gómez-Campderá F; Ridao N; Sánchez M; Dall'Anese C; Valderrábano F
    Nephrol Dial Transplant; 2001; 16 Suppl 1():78-81. PubMed ID: 11369828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lisinopril versus atenolol: decrease in systolic versus diastolic blood pressure with converting enzyme inhibition.
    Pannier BE; Garabedian VG; Madonna O; Fouchard M; Darne B; Safar ME
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):775-81. PubMed ID: 1653594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the antihypertensive effects of betaxolol to atenolol.
    Mroczek WJ; Burris JF; Hogan LB; Citron DC; Barker AH; McDonald RH
    Am J Cardiol; 1988 Apr; 61(10):807-11. PubMed ID: 2895577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of hypertensive and hypercholesterolaemic patients in general practice. The effect of captopril, atenolol and pravastatin combined with life style intervention.
    Foss OP; Graff-Iversen S; Istad H; Søyland E; Tjeldflaat L; Graving B
    Scand J Prim Health Care; 1999 Jun; 17(2):122-7. PubMed ID: 10439497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of insulin resistance by beta-blockade but not ACE-inhibition: long-term treatment with atenolol or trandolapril.
    Reneland R; Alvarez E; Andersson PE; Haenni A; Byberg L; Lithell H
    J Hum Hypertens; 2000 Mar; 14(3):175-80. PubMed ID: 10694831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of the effects of lisinopril when used in addition to atenolol.
    Soininen K; Gerlin-Piira L; Suihkonen J; Kyllönen T; Parviainen R; Kyllönen E; Hämäläinen K; Lonka R; Tikkanen T; Selonen R
    J Hum Hypertens; 1992 Aug; 6(4):321-4. PubMed ID: 1331443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.
    Widmann L; van der Does R; Hörrmann M; Machwirth M
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S143-6. PubMed ID: 1974505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin sensitivity following treatment with the alpha 1-blocker bunazosin retard and the beta 1-blocker atenolol in hypertensive non-insulin-dependent diabetes mellitus patients.
    Eriksson JW; Jansson PA; Foley K; Lithell H
    J Hypertens; 1996 Dec; 14(12):1469-75. PubMed ID: 8986932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of carvedilol with atenolol in the treatment of mild-to-moderate essential hypertension. INT-CAR-07 (U.K.) Study Group.
    Young PH
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S82-5. PubMed ID: 1378155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.